Griseofulvin is a systemic antifungal medication derived from the fungus penicillium griseofulvum. It is used to treat superficial and deep fungal infections of the skin, hair, and nails. The drug works by interfering with fungal mitosis through binding to fungal microtubules. This binding disrupts the organization of microtubules and inhibits the synthesis of fungal cell wall components. The resulting inhibition of cell division prevents the spread of the infection across the host tissue. By acting on the fungal spindle apparatus the compound reduces the ability of the pathogen to replicate. The medication's effect on protein synthesis and chromosome segregation leads to the death of susceptible organisms. Overall Griseofulvin provides a therapeutic benefit by halting fungal growth without affecting human cells in the same manner.

Griseofulvin is an oral antifungal medication used primarily for superficial dermatophyte infections. It is classified as a systemic antifungal that inhibits fungal microtubule assembly, leading to impaired cell division. The drug exerts its therapeutic effect by selectively binding to fungal keratin and interfering with nucleic acid synthesis. This interference disrupts the normal growth and replication of pathogenic fungi in the skin and hair. Because its activity depends on the presence of fungal microtubules, Griseofulvin shows limited effect against bacterial or viral organisms. Its pharmacokinetic profile involves extensive protein binding and hepatic metabolism, which prolongs its presence in the body. Clinical response typically correlates with the duration of treatment needed to eradicate the infection completely.

Griseofulvin is an oral antifungal medication used to treat certain fungal infections. Common side effects include gastrointestinal disturbances such as nausea vomiting diarrhea and abdominal pain. Central nervous system effects may present as headache dizziness or fatigue. Skin reactions can appear as rash itching or photosensitivity to sunlight. Some patients experience liver enzyme elevations which may be detected by laboratory testing. Rare but notable effects include peripheral neuropathy and blood disorders. Overall the medication is generally well tolerated when used as prescribed.

Griseofulvin may cause skin rash or itching in some patients. Headache is reported by a minority of users. Gastrointestinal disturbances such as nausea or abdominal discomfort can occur. Dizziness or lightheadedness may be experienced occasionally. Changes in taste perception have been observed in rare cases. Photosensitivity to sunlight can increase in some individuals. Fatigue or mild weakness may be noted during treatment. Most side effects are mild and often resolve without intervention.